In Vitro Simulation Testing of Absorbable Medical Materials: Degradation Evaluation, Standards, and

In vitro simulation testing is a critical step in evaluating the degradation behavior, mechanical performance, and safety of absorbable (bioresorbable) materials used in medical devices such as sutures, screws, plates, scaffolds, and stents. By exposing these materials to simulated physiological environments such as phosphate-buffered saline and simulated body fluid, accredited third-party laboratories and manufacturers can predict in vivo performance, support regulatory submissions, and accelerate product development.

Technical Overview

Absorbable materials are designed to perform a temporary mechanical or biological function in the body and then degrade safely into non-toxic products that are metabolized or excreted. Because real-time degradation in patients may take months or years, in vitro simulation testing provides a controlled, repeatable, and accelerated method to characterize how these materials behave under physiological conditions. Test specimens are immersed in media that mimic body fluids and are maintained at 37°C, often with agitation, while degradation is tracked over predetermined time points.

The core scientific principle is hydrolytic or corrosive degradation. Synthetic absorbable polymers degrade through hydrolysis of ester bonds, leading to reduced molecular weight, loss of mass, and declining mechanical strength. Absorbable metals degrade electrochemically, releasing metallic ions and generating hydrogen. In vitro testing quantifies these processes and establishes degradation timelines, mass loss kinetics, pH drift, and residual strength profiles that inform device design and risk assessment.

Testing is guided by recognized international standards, including ASTM F1635, ASTM F2902, ASTM F3268, ISO 13781, ISO 15814, ISO 10993-13/-14/-15, and ISO 23317. Results are commonly used to support design verification, preclinical justifications, and regulatory dossiers submitted to authorities under frameworks aligned with ISO 13485 quality management systems.

Testing Samples

Synthetic Absorbable Polymers

Representative materials include poly(L-lactide) (PLLA), poly(D,L-lactide) (PDLLA), polyglycolide (PGA), poly(lactide-co-glycolide) (PLGA), polycaprolactone (PCL), polydioxanone (PDO), and trimethylene carbonate copolymers. Samples may be submitted as raw resin pellets, compression-molded plaques, extruded rods, films, fibers, or injection-molded test coupons.

Absorbable Metals

Magnesium-based alloys (for example Mg-Zn-Ca and rare-earth-containing alloys), zinc-based alloys, and iron-based alloys are evaluated for uniform corrosion rate, pitting susceptibility, gas evolution, and ion release under simulated physiological conditions.

Absorbable Ceramics and Composite Materials

Calcium phosphate cements, hydroxyapatite, beta-tricalcium phosphate, bioactive glasses, and polymer-ceramic composites are tested for dissolution, apatite-forming ability, and structural integrity, often using simulated body fluid prepared according to ISO 23317.

Fabricated Medical Devices

Finished or near-final devices such as interference screws, suture anchors, plates and pins, craniofacial meshes, monofilament and braided sutures, wound-closure devices, cardiovascular bioresorbable scaffolds, tissue-engineering scaffolds, adhesion barriers, and drug-release depots can be tested in their as-implanted geometry to capture realistic device-level degradation.

Testing Items

A comprehensive in vitro simulation study typically measures the following parameters at each degradation time point:

• Mass change, mass loss percentage, and water absorption (swelling) ratio
• Molecular weight retention (weight-average, number-average, and polydispersity index) by gel permeation chromatography
• Mechanical property retention, including tensile strength, flexural strength, shear strength, and burst or radial strength for tubular devices
• pH drift of the degradation medium and lactic/glycolic acid accumulation
• Thermal properties by differential scanning calorimetry, including glass transition, melting point, and crystallinity evolution
• Surface and cross-sectional morphology by scanning electron microscopy, with elemental analysis where applicable
• Chemical structure changes by Fourier-transform infrared spectroscopy and nuclear magnetic resonance
• Corrosion metrics for absorbable metals, including corrosion rate, hydrogen evolution, and released ion concentrations by ICP-MS or ICP-OES
• Dimensional stability, geometric integrity, and visual appearance grading
• Optional cytotoxicity screening of degradation extracts according to ISO 10993-5

Testing Methods

Test Media Preparation

Common media include phosphate-buffered saline, simulated body fluid per ISO 23317, Tris-HCl buffered saline, and Hank's balanced salt solution. Media are prepared with ultrapure water, sterile-filtered, pH-adjusted to approximately 7.4, and pre-equilibrated to 37°C. Media selection should reflect the intended implantation site and the degradation mechanism under study.

Immersion Protocol

Specimens are placed in sealed containers with a defined medium volume-to-sample ratio, commonly following the minimum liquid-to-mass or surface-area requirements described in ASTM F1635, ISO 10993-12, and ISO 10993-13. Containers are incubated at 37°C under static or dynamic conditions, with orbital agitation or perfusion used when shear or fluid movement is clinically relevant. Degradation time points may range from several days to 52 weeks or longer, depending on the expected absorption profile. Medium replacement schedules and pH monitoring intervals are pre-defined to avoid depletion of buffering capacity or accumulation of acidic products that could artificially distort degradation kinetics.

Retrieval and Analytical Characterization

At each time point, replicate specimens are retrieved, gently dried to a consistent conditioned state, and subjected to gravimetric analysis, mechanical testing, and materials characterization. Tensile testing is typically performed per ISO 527 or ASTM D638, flexural testing per ISO 178, and device-specific strength tests per applicable ASTM device standards. Molecular weight is measured by gel permeation chromatography calibrated with appropriate polymer standards, and morphology is documented by scanning electron microscopy before and after degradation.

Electrochemical Testing for Absorbable Metals

Metallic specimens may undergo immersion corrosion testing per ASTM G31, potentiodynamic polarization per ASTM G5, linear polarization resistance per ASTM G59, and electrochemical impedance spectroscopy to derive instantaneous corrosion rates. Hydrogen evolution collection and quantitative ion analysis complement gravimetric mass loss measurements, as recommended by ASTM F3268.

Applications

In vitro simulation testing of absorbable materials supports product development and regulatory clearance across a wide range of medical specialties:

• Orthopedic and sports medicine implants, including bioabsorbable interference screws, suture anchors, pins, and plates where strength retention curves must match bone healing timelines
• Craniofacial and maxillofacial fixation devices requiring predictable resorption without inflammatory response
• Cardiovascular bioresorbable vascular scaffolds, where radial strength loss, polymer erosion, and drug release must be coordinated
• General surgery and wound closure products such as absorbable sutures, meshes, clips, and adhesion barriers
• Tissue-engineering and regenerative medicine scaffolds, where degradation rate must be matched to tissue ingrowth
• Localized drug-delivery systems, including microspheres and depots that release therapeutics as the carrier erodes
• Regulatory documentation, including design verification reports, preclinical study justifications, and technical files for market submission

FAQ

Why is in vitro simulation testing necessary before animal studies?

In vitro testing isolates the degradation behavior of the material from biological variability, providing controlled, reproducible data on mass loss, molecular weight decline, and strength retention. These results define appropriate time points and endpoints for subsequent in vivo studies, reduce animal use, and strengthen the scientific justification in regulatory submissions.

Which degradation medium should be chosen: PBS or simulated body fluid?

Phosphate-buffered saline is widely used for hydrolytic degradation of absorbable polymers because it offers stable pH and good comparability with historical data. Simulated body fluid prepared per ISO 23317 contains ion concentrations close to human blood plasma and is preferred when evaluating apatite-forming ability, bioactivity of ceramics, or corrosion of absorbable metals under more physiological ionic conditions.

How are degradation time points selected?

Time points are chosen to bracket the clinically relevant absorption window, for example at 1, 2, 4, 8, 12, 26, and 52 weeks for slowly resorbing PLLA devices, or at daily to weekly intervals for rapidly degrading PLGA or magnesium alloys. A pilot kinetic study or accelerated testing per ISO 13781 can help refine the schedule.

What is the typical acceptance criterion for degradation testing?

Acceptance criteria are device-specific. Common examples include retaining a defined percentage of initial mechanical strength at the clinically required healing interval, maintaining pH drift within a biocompatible range, and demonstrating complete mass loss within the claimed absorption period. Criteria must be justified against the intended clinical use.

Can finished sterilized devices be tested directly?

Yes. Testing sterilized, final-form devices is recommended because sterilization methods such as ethylene oxide and gamma irradiation can alter molecular weight and degradation kinetics. Testing the device in its as-delivered state provides the most representative degradation profile for regulatory review.